✦ LIBER ✦

Sorafenib: Recent Update on Activity as a Single Agent and in Combination with Interferon-α2 in Patients with Advanced-Stage Renal Cell Carcinoma

✍ Scribed by G. Kesava Reddy; Ronald M. Bukowski

Book ID: 119935384
Publisher: CIG Media Group, LP.
Year: 2006
Tongue: English
Weight: 871 KB
Volume: 4
Category: Article
ISSN: 1558-7673
DOI: 10.3816/cgc.2006.n.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of advanced renal cell cancer

Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate

✍ F. Porzsolt; D. Messerer; R. Hautmann; A. Gottwald; H. Sparwasser; K. Stockamp; 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 English ⚖ 602 KB

Combination therapy with capecitabine an

Combination therapy with capecitabine and interferon alfa-2A in patients with advanced renal cell carcinoma: A phase II study

✍ Peeter Padrik; Krista Leppik; Andrus Arak 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Progressive anemia following combination

Progressive anemia following combination therapy with interferon-α and interleukin-2 in a patient with metastatic renal cell carcinoma

✍ YUKINARI HOSOKAWA; TATSUKI KISHINO; TAKAMASA ONO; NOBUO OYAMA; KUNIO HAYASHI; HI 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

883 POSTER Phase I trial of sorafenib (B

883 POSTER Phase I trial of sorafenib (BAY 43–9006) in combination with interferon alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma and malignant melanoma

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Clinical outcome and prognostic survival

Clinical outcome and prognostic survival factors in patients with advanced renal cell carcinoma treated with very low-dose interleukin-2, interferon-α, and tegafur-uracil: a single-institution experience

✍ Minoru Kobayashi; Hitoshi Ikeda; Akinori Nukui; Kazumi Suzuki; Yasuhiro Sugaya; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 336 KB

Single agent versus combination chemothe

Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma : A meta-analysis of response, toxicity, and survival

✍ Rogerio C. Lilenbaum; Patricia Langenberg; Kay Dickersin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views

## Background: This meta-analysis was conducted to compare the effects of single agent versus combination chemotherapy on response rate, toxicity, and survival of patients with advanced nonsmall cell lung carcinoma (nsclc). ## Methods: The authors reviewed randomized clinical trials published in